14/12/2005
SLS Venture sells its 23 per cent ownership in Carmel Pharma AB. Read more >>
15/11/2005
Normalt rörelseschema återställt och nya hjärnceller bildade i Parkinsonmodell. Read more >> 14/11/2005
Boehringer Ingelheim and Biolipox sign agreement on a new class
of drugs to treat pain and inflammation. Read more >> 03/10/2005
Karin Hehenberger new Senior Investment Director at SLS Venture. Read more >> 24/08/2005
Nyemission i Aerocrine öppnar dörren för Europalansering av astmatest. Read more >> 23/08/2005
Symphogen A/S and Cambridge Antibody Technology sign
patent licensing agreement. Read more >> 23/08/2005
Arpida receives FDA fast track designation for intravenous iclaprim. Read more >> 13/07/2005
Arpida granted ind for oral iclaprim from us FDA. Read more >> 11/07/2005
External financing of SEK 165 million secured for Q-Med’soxalate project. Read more >> 01/07/2005
E&Y Global Biotech Report 2005 "Beyond Borders". Taking Root: Stem Cells
and Neurogenesis. Read more >> 01/07/2005
E&Y Global Biotech Report 2005 "Beyond Borders". The Quest for Stem Cell Products. Read more >> 21/06/2005
Nuevolution A/S signs agreement with Schering AG on drug discovery. Read more >> 20/06/2005
Symphogen A/S appoints Paul Rohricht as Vice President of Busniess Development. Read more >> 13/06/2005
Nuevolution A/S and Biovitrum AB in drug discovery collaboration. Read more >>
